Cytokinetics Inc (NASDAQ:CYTK)

6.26
Delayed Data
As of 4:00pm ET
 -0.04 / -0.63%
Today’s Change
3.05
Today|||52-Week Range
8.61
-21.85%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close6.30
Today’s open6.26
Day’s range6.16 - 6.35
Volume152,597
Average volume (3 months)366,218
Market cap$235.8M
Dividend yield--
Data as of 4:00pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)+66.94%
Earnings growth (this year)-193.90%
Earnings growth (next 5 years)--
Revenue growth (last year)+53.16%
P/E ratioNM
Price/Sales6.09
Price/Book2.56

Competitors

 Today’s
change
Today’s
% change
NATRNatures Sunshine Pro...+0.20+1.58%
CDTXCidara Therapeutics ...-0.08-0.51%
NUTRNutraceutical Intern...+0.26+1.21%
LJPCLa Jolla Pharmaceuti...+0.05+0.25%
Data as of 4:00pm ET, 05/28/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$46.9M
Annual profit (last year)-$14.6M
Net profit margin-31.20%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers